Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > BUSINESS
BUSINESS
- Diabetes Treatments: Their Development and Market
February 20, 2012
- With Upcoming Price Cuts, Nursing Homes Present Opportunity for Makers of Generic AD Treatments
February 20, 2012
- Fuso Acquires Exclusive Domestic Marketing Rights to Mucus Bulging Agent
February 20, 2012
- Daiichi Sankyo, Roche Announce Approval of Malignant Melanoma Treatment Vemurafenib in EU
February 20, 2012
- 6 SGLT-2 Inhibitors in Final Development Stage, Applications Expected in 2013
February 17, 2012
- Qol Expects to Clear “30%” Generic Dispensing Mark Around October
February 17, 2012
- 40% of Doctors Prescribe Existing Drugs Until New Drug Information Is Clarified: Survey
February 17, 2012
- Daiichi Sankyo, Pfizer Obtain Approval for Their Competition Generics for June Listing
February 17, 2012
- EC Approves Add’l Indication of CHF for Ion Channel Inhibitor Ivabradine: Ono
February 17, 2012
- Drugstore Chains to Appeal Directly to Public in Support of “Dispensing Point” Services
February 17, 2012
- Sanofi-aventis Nichi-Iko Obtains Approval for Allegra Generic Ahead of Competitors
February 16, 2012
- UMN Obtains Worldwide Rights for Norovirus and Rotavirus Combined Vaccine
February 16, 2012
- Pfizer Obtains Approval for Generics of 10 APIs
February 16, 2012
- Maruho Acquires Venture in Bid to Develop US Business Base
February 15, 2012
- Celecox Ranked Top Place in HP Market: RepTrack Survey
February 15, 2012
- MSD Issues Precaution for Gardasil on Syncope, Falls
February 15, 2012
- MSD Cautions against Syncope, Fall after Gardasil Vaccination
February 15, 2012
- Major Pharmacy Chains to Boost Efforts to Raise GE Dispensing Rates Despite Dissatisfaction with Revised Premiums
February 15, 2012
- Altheos Initiates PIIa Trial for ATS907 in the US: Asahi Kasei Pharma
February 14, 2012
- Sawai Wins Patent Lawsuit on Ebastine
February 14, 2012
ページ
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…